A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis

Clinical trial NCT02499562 · COMPLETED

Trial details

NCT number: NCT02499562
Sponsor: Shanghai Genomics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis B, Chronic

Start date: 2015-06-25
Primary completion: 2020-11-20
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.